MEHLMAN CONSULTING, INC.

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES · Trade Association

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 17, 2025

Lobbying activity 3

Medicare/Medicaid

Issues related to generic medicines.

Health Issues

Issues related to generic medicines. issues related to generic and biosimilar medications.

Pharmacy

Issues related to pharmaceutical manufacturing supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.